Endophthalmitis

Last updated
Endophthalmitis
Other namesEndophthalmia
Hypopyon 1.jpg
Hypopyon with hazy media
Specialty Ophthalmology

Endophthalmitis, or endophthalmia, is inflammation of the interior cavity of the eye, usually caused by an infection. It is a possible complication of all intraocular surgeries, particularly cataract surgery, and can result in loss of vision or loss of the eye itself. [1] Infection can be caused by bacteria or fungi, and is classified as exogenous (infection introduced by direct inoculation as in surgery or penetrating trauma), or endogenous (organisms carried by blood vessels to the eye from another site of infection and is more common in people who have an immunocompromised state). Other non-infectious causes include toxins, allergic reactions, and retained intraocular foreign bodies. Intravitreal injections are a rare cause, with an incidence rate usually less than 0.05%.

Contents

Endophthalmitis requires immediate medical attention to ensure the condition is diagnosed as soon as possible and treatment is started in order to reduce the risk of the person losing vision in the eye. [2] Treatment options depend on the cause and whether the condition is cause by an endogenous or exogenous mechanism. For people with suspected exogenous endophthalmitis, a biopsy (vitreous tap) and treatment with antibiotics (usually by injection) is usually the first line of treatment. [2] Once the person's response to the antibiotics is assessed, different further treatment options may be considered including surgery.

Signs and symptoms

Symptoms of endophthalmitis include severe eye pain, vision loss, and intense redness of the conjunctiva. [1] Bacterial endophthalmitis more commonly presents with severe and sudden symptoms whereas fungal causes have a more insidious onset and severity, with 80% of ocular candidiasis (both chorioretinitis and endophthalmitis) being asymptomatic. [3] Hypopyon, or inflammatory cells in the anterior chamber of the eye may be present. [3] In endogenous endophthalmitis systemic signs and symptoms may be present, including fevers, chills, mental status changes, hypotension or other signs of sepsis. [3] 8-20% of endogenous endophthalmitis affect both eyes. [3] In both endogenous and exogenous types of endophthalmitis, approximately 20% of people will experience severe vision loss. [3]

Complications

Cause

A recent systematic review found that the most common source of infectious transmission following cataract surgery was attributed to a contaminated intaocular solution (i.e. irrigation solution, viscoelastic, or diluted antibiotic), although there is a large diversity of exogenous microorganisms that can travel via various routes including the operating room environment, phacoemulsifcation machine, surgical instruments, topical anesthetics, intraocular lens, autoclave solution, and cotton wool swabs. [6]

Late-onset endophthalmitis is mostly caused by Cutibacterium acnes. [7]

Causative organisms are not present in all cases. Endophthalmitis can emerge by entirely sterile means, e.g. an allergic reaction to a drug administered intravitreally.

Exogenous endophthalmitis is estimated to occur in 0.04 to 0.1% of all cataract surgeries and intravitreal injections. Whereas 0.9 to 10% of all penetrating eye trauma is complicated by exogenous endophthalmitis. [3] Risk factors for the development of endophthalmitis after penetrating eye trauma include a delay (usually greater than 24 hours) in closure of the wound, metal objects being involved in the trauma, disruption of the lens and a retained foreign body in the eye. [3] Bacillus cereus associated endophthalmitis is characterized by an especially fulminant clinical course and rapid vision loss. [3]

Endogenous endophthalmitis is estimate to comprise 2-15% of all endophthalmitis. [3] Diagnosis may be challenging as 30-60% of those with endogenous endophthalmitis are afebrile, with blood cultures being positive in only 30-55% of cases, and only 6% in those with candidal endophthalmitis. [3] Fungal sources of endogenous endophthalmitis are usually seen in those who are immunocompromised, with IV drug use and central venous catheter also being important risk factors. [3] The incidence of endophthalmitis associated with drug use has increased 4-fold from 2003 to 2016. [3]

Diagnosis

Endophthalmitis is clinically diagnosed based on signs, symptoms, eye and general examination, with the diagnosis being confirmed by intra-ocular microbiological culture (with the aqueous humour or vitreous humour extracted by vitrectomy or a vitreous or aqueous aspirate). [3] In cases of endogenous endophthalmitis (due to endogenous sources causing bacteremia or fungemia), blood cultures may be obtained and aid in the diagnosis. 30% of infectious endophthalmitis are culture negative, with cultures more commonly being negative in fungal causes of endophthalmitis. [3]

Prevention

Different approaches have been suggested to prevent exogenous endophthalmitis after cataract surgery. Perioperative antibiotic injections into the eye, specifically cefuroxime at the end of surgery, lowers the chance of endophthalmitis. [8] Moderate evidence also supports antibiotic eye drops (levofloxacin or chloramphenicol) with antibiotic injections (cefuroxime or penicillin) to reduce the risk of endophthalmitis after cataract surgery compared with injections or eye drops alone. [8] Periocular injection of penicillin along with chloramphenicol-suphadimidine eye drops and an intracameral cefuroxime injection with topical levofloxacin also reduces the risk reduction of developing endophthalmitis following cataract surgery for some people. [9] [10]

For people undergoing intravitreal injections, antibiotics are not as effective at preventing this type of infection. Studies have demonstrated no difference between rates of infection with and without antibiotics when intravitreal injections are performed. [11] There is evidence to suggest that a solution of povidone-iodine and antibiotics applied pre-injection may be effective at preventing some cases of endophthalmitis in people undergoing intravitreal injections. [12]

Intravenous antibiotics given prophylactically in those with penetrating eye trauma has shown a reduction in the incidence of exogenous endophthalmitis. [3]

Treatment

Urgent medical attention is required if a person has suspected endophthalmitis. Intravitreal injection of antibiotics are indicated in bacterial endophthalmitis. [2] Intravitreal injections of vancomycin (targeted against Gram-positive bacteria) and ceftazidime (targeting Gram-negative bacteria) are routine. Even though antibiotics can have negative impacts on the retina in high concentrations, since visual acuity worsens in 65% of endophthalmitis patients and prognosis gets poorer the longer an infection goes untreated, most medical professionals make the clinical judgment decision that immediate intervention with antibiotics is necessary. [13] Fungal pathogens are treated with intravitreal injections of amphotericin B or voriconazole. [3] Systemic antibiotics or anti-fungals are used in those with endogenous endophthalmitis with associated bactermia or fungemia. [3] People with endophthalmitis may also require an urgent surgery (pars plana vitrectomy). [2] In some cases, evisceration may be necessary to remove a severe and intractable infection which could result in a blind and painful eye.

In people with acute endophthalmitis, combined steroid treatment with antibiotics have been found to improve visual outcomes, versus patients only treated with antibiotics, but any improvements on the resolution acute endophthalmitis is unknown. [14]

Related Research Articles

<span class="mw-page-title-main">Diabetic retinopathy</span> Medical condition

Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes. It is a leading cause of blindness in developed countries.

<span class="mw-page-title-main">Cataract</span> Clouding of the lens inside the eye, causing poor vision

A cataract is a cloudy area in the lens of the eye that leads to a decrease in vision of the eye. Cataracts often develop slowly and can affect one or both eyes. Symptoms may include faded colours, blurry or double vision, halos around light, trouble with bright lights, and difficulty seeing at night. This may result in trouble driving, reading, or recognizing faces. Poor vision caused by cataracts may also result in an increased risk of falling and depression. Cataracts cause 51% of all cases of blindness and 33% of visual impairment worldwide.

<span class="mw-page-title-main">Floater</span> Deposits within the eyes vitreous humour

Floaters or eye floaters are sometimes visible deposits within the eye's vitreous humour, which is normally transparent, or between the vitreous and retina. They can become particularly noticeable when looking at a blank surface or an open monochromatic space, such as blue sky. Each floater can be measured by its size, shape, consistency, refractive index, and motility. They are also called muscae volitantes, or mouches volantes. The vitreous usually starts out transparent, but imperfections may gradually develop as one ages. The common type of floater, present in most people's eyes, is due to these degenerative changes of the vitreous. The perception of floaters, which may be annoying or problematic to some people, is known as myodesopsia, or, less commonly, as myodaeopsia, myiodeopsia, or myiodesopsia. It is not often treated, except in severe cases, where vitrectomy (surgery), laser vitreolysis, and medication may be effective.

<span class="mw-page-title-main">Vitrectomy</span> Surgery to remove vitreous humor from the eye

Vitrectomy is a surgery to remove some or all of the vitreous humor from the eye.

<span class="mw-page-title-main">Phacoemulsification</span> Method of cataract surgery

Phacoemulsification is a cataract surgery method in which the internal lens of the eye which has developed a cataract is emulsified with the tip of an ultrasonic handpiece and aspirated from the eye. Aspirated fluids are replaced with irrigation of balanced salt solution to maintain the volume of the anterior chamber during the procedure. This procedure minimises the incision size and reduces the recovery time and risk of surgery induced astigmatism.

<span class="mw-page-title-main">Retinal detachment</span> Medical condition of the eye

Retinal detachment is a disorder of the eye in which the retina peels away from its underlying layer of support tissue. Initial detachment may be localized, but without rapid treatment the entire retina may detach, leading to vision loss and blindness. It is a surgical emergency.

<span class="mw-page-title-main">Cefuroxime</span> Antibiotic medication

Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin antibiotic used to treat and prevent a number of bacterial infections. These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease. It is used by mouth or by injection into a vein or muscle.

<span class="mw-page-title-main">Cataract surgery</span> Removal of opacified lens from the eye

Cataract surgery, also called lens replacement surgery, is the removal of the natural lens of the eye that has developed a cataract, an opaque or cloudy area. The eye's natural lens is usually replaced with an artificial intraocular lens (IOL) implant.

<span class="mw-page-title-main">Eye injury</span> Physical or chemical injuries of the eye

Physical or chemical injuries of the eye can be a serious threat to vision if not treated appropriately and in a timely fashion. The most obvious presentation of ocular (eye) injuries is redness and pain of the affected eyes. This is not, however, universally true, as tiny metallic projectiles may cause neither symptom. Tiny metallic projectiles should be suspected when a patient reports metal on metal contact, such as with hammering a metal surface. Corneal foreign bodies are one of the most common preventable occupational hazards. Intraocular foreign bodies do not cause pain because of the lack of nerve endings in the vitreous humour and retina that can transmit pain sensations. As such, general or emergency department doctors should refer cases involving the posterior segment of the eye or intraocular foreign bodies to an ophthalmologist. Ideally, ointment would not be used when referring to an ophthalmologist, since it diminishes the ability to carry out a thorough eye examination.

Staphylococcus lugdunensis is a coagulase-negative member of the genus Staphylococcus, consisting of Gram-positive bacteria with spherical cells that appear in clusters.

<span class="mw-page-title-main">Intravitreal administration</span>

Intravitreal administration is a route of administration of a drug, or other substance, in which the substance is delivered into the vitreous humor of the eye. "Intravitreal" literally means "inside an eye". Intravitreal injections were first introduced in 1911 when Ohm gave an injection of air into the vitreous humor to repair a detached retina. In the mid-1940s, intravitreal injections became a standard way to administer drugs to treat endophthalmitis and cytomegalovirus retinitis.

<span class="mw-page-title-main">Intermediate uveitis</span> Medical condition

Intermediate uveitis is a form of uveitis localized to the vitreous and peripheral retina. Primary sites of inflammation include the vitreous of which other such entities as pars planitis, posterior cyclitis, and hyalitis are encompassed. Intermediate uveitis may either be an isolated eye disease or associated with the development of a systemic disease such as multiple sclerosis or sarcoidosis. As such, intermediate uveitis may be the first expression of a systemic condition. Infectious causes of intermediate uveitis include Epstein–Barr virus infection, Lyme disease, HTLV-1 virus infection, cat scratch disease, and hepatitis C.

<span class="mw-page-title-main">Branch retinal vein occlusion</span> Medical condition

Branch retinal vein occlusion is a common retinal vascular disease of the elderly. It is caused by the occlusion of one of the branches of central retinal vein.

<span class="mw-page-title-main">Vitreomacular adhesion</span> Human medical condition

Vitreomacular adhesion (VMA) is a human medical condition where the vitreous gel of the human eye adheres to the retina in an abnormally strong manner. As the eye ages, it is common for the vitreous to separate from the retina. But if this separation is not complete, i.e. there is still an adhesion, this can create pulling forces on the retina that may result in subsequent loss or distortion of vision. The adhesion in of itself is not dangerous, but the resulting pathological vitreomacular traction (VMT) can cause severe ocular damage.

Open-globe injuries are full-thickness eye-wall wounds requiring urgent diagnosis and treatment.

<span class="mw-page-title-main">Intracameral injection</span>

An intracameral injection is usually of an antibiotic into the anterior chamber of the eyeball to prevent endophthalmitis caused by an infection of the eye that can occur after cataract surgery. The Food and Drug Administration (FDA) has not approved antibiotics for this use and it is considered 'off-label'. Concerns about this procedure contributing to increasing numbers of antibiotic resistant bacteria have been expressed.

<span class="mw-page-title-main">Intravitreal injection</span> Method of administration of drugs into the eye by injection with a fine needle

Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor. It is used to treat various eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye such as endophthalmitis. As compared to topical administration, this method is beneficial for a more localized delivery of medications to the targeted site, as the needle can directly pass through the anatomical eye barrier and dynamic barrier. It could also minimize adverse drug effects on other body tissues via the systemic circulation, which could be a possible risk for intravenous injection of medications. Although there are risks of infections or other complications, with suitable precautions throughout the injection process, chances for these complications could be lowered.

<span class="mw-page-title-main">Secondary glaucoma</span>

Secondary glaucoma is a collection of progressive optic nerve disorders associated with a rise in intraocular pressure (IOP) which results in the loss of vision. In clinical settings, it is defined as the occurrence of IOP above 21 mmHg requiring the prescription of IOP-managing drugs. It can be broadly divided into two subtypes: secondary open-angle glaucoma and secondary angle-closure glaucoma, depending on the closure of the angle between the cornea and the iris. Principal causes of secondary glaucoma include optic nerve trauma or damage, eye disease, surgery, neovascularization, tumours and use of steroid and sulfa drugs. Risk factors for secondary glaucoma include uveitis, cataract surgery and also intraocular tumours. Common treatments are designed according to the type and the underlying causative condition, in addition to the consequent rise in IOP. These include drug therapy, the use of miotics, surgery or laser therapy.

Panuveitis also known as Diffuse uveitis or Total uveitis is an eye disease affecting the internal structures of the eye. In this inflammation occurs throughout the uveal tract, with no specific areas of predominant inflammation. In most cases, along with the uvea, the retina, vitreous humor, optic nerve or lens are also involved.

Manual small incision cataract surgery (MSICS) is an evolution of extracapsular cataract extraction (ECCE); the lens is removed from the eye through a self-sealing scleral tunnel wound. A well-constructed scleral tunnel is held closed by internal pressure, is watertight, and does not require suturing. The wound is relatively smaller than that in ECCE but is still markedly larger than a phacoemulsification wound. Comparative trials of MSICS against phaco in dense cataracts have found no statistically significant difference in outcomes but MSICS had shorter operating times and significantly lower costs. MSICS has become the method of choice in the developing world because it provides high-quality outcomes with less surgically induced astigmatism than ECCE, no suture-related problems, quick rehabilitation, and fewer post-operative visits. MSICS is easy and fast to learn for the surgeon, cost effective, simple, and applicable to almost all types of cataract.

References

  1. 1 2 Oiseth S, Jones L, Maza E, eds. (10 November 2022). "Endophthalmitis". The Lecturio Medical Concept Library. Retrieved 19 July 2021.
  2. 1 2 3 4 Muqit MM, Mehat M, Bunce C, Bainbridge JW, et al. (Cochrane Eyes and Vision Group) (November 2022). "Early vitrectomy for exogenous endophthalmitis following surgery". The Cochrane Database of Systematic Reviews. 2022 (11): CD013760. doi:10.1002/14651858.CD013760.pub2. PMC   9672977 . PMID   36398614.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Durand, Marlene L.; Barshak, Miriam B.; Sobrin, Lucia (21 December 2023). "Eye Infections". New England Journal of Medicine. 389 (25): 2363–2375. doi:10.1056/NEJMra2216081.
  4. 1 2 3 Goldenberg DT, Harinandan A, Walsh MK, Hassan T (Spring 2010). "Serratia marcescens endophthalmitis after 20-gauge pars plana vitrectomy". Retinal Cases & Brief Reports. 4 (2): 140–142. doi:10.1097/ICB.0b013e31819955bf. PMID   25390387.
  5. 1 2 3 4 Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12th Edition. Mosby Elsevier, 2007. p. 834.
  6. ↑ Park J, Popovic MM, Balas M, El-Defrawy SR, Alaei R, Kertes PJ (January 2022). "Clinical features of endophthalmitis clusters after cataract surgery and practical recommendations to mitigate risk: systematic review". Journal of Cataract and Refractive Surgery. 48 (1): 100–112. doi: 10.1097/j.jcrs.0000000000000756 . PMID   34538777. S2CID   237574618.
  7. ↑ Shirodkar AR, Pathengay A, Flynn HW, Albini TA, Berrocal AM, Davis JL, et al. (March 2012). "Delayed- versus acute-onset endophthalmitis after cataract surgery". American Journal of Ophthalmology. 153 (3): 391–398.e2. doi:10.1016/j.ajo.2011.08.029. PMC   3381653 . PMID   22030353.
  8. 1 2 Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell PJ (February 2017). "Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery". The Cochrane Database of Systematic Reviews. 2017 (2): CD006364. doi:10.1002/14651858.CD006364.pub3. PMC   5375161 . PMID   28192644.
  9. ↑ Christy NE, Sommer A (August 1979). "Antibiotic prophylaxis of postoperative endophthalmitis". Annals of Ophthalmology. 11 (8): 1261–1265. PMID   318049.
  10. ↑ Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons (June 2007). "Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors". Journal of Cataract and Refractive Surgery. 33 (6): 978–988. doi: 10.1016/j.jcrs.2007.02.032 . PMID   17531690. S2CID   37697458.
  11. ↑ Benoist d'Azy C, Pereira B, Naughton G, Chiambaretta F, Dutheil F (2016-06-03). "Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis". PLOS ONE. 11 (6): e0156431. Bibcode:2016PLoSO..1156431B. doi: 10.1371/journal.pone.0156431 . PMC   4892688 . PMID   27257676.
  12. ↑ de Caro JJ, Ta CN, Ho HK, Cabael L, Hu N, Sanislo SR, et al. (June 2008). "Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections". Retina. 28 (6): 877–883. doi:10.1097/IAE.0b013e31816b3180. PMID   18536606. S2CID   25819637.
  13. ↑ Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C (July 2015). "Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome". American Journal of Ophthalmology. 160 (1): 17–25.e1. doi:10.1016/j.ajo.2015.04.013. PMID   25892127.
  14. ↑ Emami S, Kitayama K, Coleman AL (June 2022). "Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 2022 (6): CD012131. doi:10.1002/14651858.CD012131.pub3. PMC   9169535 . PMID   35665485.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.